Heumann Pharma competitive analysis

Explore patent oppositions filed by Heumann Pharma against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Jun 25, 2026
Patent NumberTitleApplicantOpposition Date
S1P Receptor Modulators For Treating Multiple SclerosisNOVARTISDec 5, 2022
Amorphous Lercanidipine HydrochlorideRECORDATI INDUSTRIA CHIMICA E FARMACEUTICAAug 4, 2020

Latest PTAB cases involving Heumann Pharma

Discover the latest PTAB cases involving Heumann Pharma, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Heumann Pharma with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Jun 25, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
HEUMANN PHARMA2 - - -
NOVARTIS6526 - 21
RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA - 7 - -
RECORDATI IRELAND - 7 - -